trending Market Intelligence /marketintelligence/en/news-insights/trending/n-7jmnb80e1cisiypodupg2 content esgSubNav
In This List

Pacific Biosciences plans common stock offering

Blog

Insight Weekly: Unease roils markets; US likely to slip into recession; firms' cash ratios fall

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch


Pacific Biosciences plans common stock offering

Pacific Biosciences of California Inc. is planning a public offering of its common shares.

The Menlo Park, Calif.-based company intends to grant the underwriters an option to buy up to an additional 15% of the shares sold in the offering.

Pacific Biosciences intends to use the net proceeds from the offering for general corporate purposes, including capital expenditures and working capital. It may also use part of the proceeds to acquire or invest in complementary businesses and technologies.

Cowen and Co. LLC and Cantor Fitzgerald & Co. are acting as the joint book-running managers for the offering.

Pacific Biosciences is a life sciences company that develops sequencing systems to help scientists resolve genetically complex problems.